Working… Menu

A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02477540
Recruitment Status : Withdrawn (Study was stopped by sponsers internal reason.)
First Posted : June 22, 2015
Last Update Posted : March 22, 2019
Information provided by (Responsible Party):
Pharmicell Co., Ltd.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020